With Chief Executive Elon Musk playing a prominent role in the Trump administration, many Tesla drivers are no longer happy ...
He claims the carmaker will be the most valuable AI company in the world thanks to the reams of video data collected by its ...
Various factors have weighed on tech stocks this year, including investor unease over Trump's tariffs and AI spending.
Nick Setyan - Wedbush Securities Inc ... 1 of the premier power centers in the Bay Area. Next, we'll open a company-owned SDK in Los Angeles, California in Westwood Village.
Wall Street's biggest bull explains why Tesla investors are getting too overwrought by concerns over Elon Musk's close ties ...
Wildfires that destroyed two neighborhoods made the state’s housing shortage even worse. Now, opposition is growing to ...
The newly opened downtown club hopes to bring diversity, discovery and big laughs to L.A. night life with major talents such ...
The Simon Wiesenthal Center now has a mobile Museum of Tolerance that is touring across California for those who can't visit ...
Wedbush has a “Outperform” rating and a $90.00 price objective on the stock. The consensus estimate for Apogee Therapeutics’ current full-year earnings is ($3.09) per share.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results